During the past decade, Fondazione Toscana "G. Monasterio" Ospedale del Cuore G. Pasquinucci conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fondazione Toscana "G. Monasterio" Ospedale del Cuore G. Pasquinucci" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "4Tech Cardio Ltd." with 1 trials sponsored, "Chiesi Farmaceutici S.p.A." with 1 trials sponsored, "Corcym S.r.l" with 1 trials sponsored and "Edwards Lifesciences" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione Toscana "G. Monasterio" Ospedale del Cuore G. Pasquinucci" #1 collaborator was "Edwards Lifesciences" with 1 trials as a collaborator and "Foundation for Medical Research in Krakow, Poland" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Fondazione Toscana "G. Monasterio" Ospedale del Cuore G. Pasquinucci" are "Acute Coronary Syndrome" (2 trials), "Aortic Valve Stenosis" (2 trials), "Atrial Fibrillation" (2 trials), "Aortic Stenosis" (1 trials) and "Cardiac Valve Disease" (1 trials). Many other conditions were trialed in "Fondazione Toscana "G. Monasterio" Ospedale del Cuore G. Pasquinucci" in a lesser frequency.

Most popular intervention types in "Fondazione Toscana "G. Monasterio" Ospedale del Cuore G. Pasquinucci" are "Device" (3 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACURATE neo™ Aortic Bioprosthesis" (1 trials), "Aspirin" (1 trials), "Clopidogrel or Ticagrelor" (1 trials), "Dabigatran Etexilate 110mg" (1 trials) and "Dabigatran Etexilate 150mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione Toscana "G. Monasterio" Ospedale del Cuore G. Pasquinucci" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Fondazione Toscana "G. Monasterio" Ospedale del Cuore G. Pasquinucci". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Fondazione Toscana "G. Monasterio" Ospedale del Cuore G. Pasquinucci, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione Toscana "G. Monasterio" Ospedale del Cuore G. Pasquinucci, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".